Sol-Melcort



Indications and Reactions:

Role Indications Reactions
Primary
Anaphylactic Reaction 100.0%
Cerebral Infarction 33.3%
Hypertrophic Cardiomyopathy 33.3%
Renal Impairment 33.3%
Secondary
Prophylaxis Against Graft Versus Host Disease 11.0%
Infection Prophylaxis 10.0%
Renal Transplant 9.5%
Rheumatoid Arthritis 9.5%
Prophylaxis 8.8%
Product Used For Unknown Indication 6.8%
Bone Marrow Conditioning Regimen 6.3%
Interstitial Lung Disease 5.5%
Hypertension 5.0%
Premedication 4.5%
Liver Transplant Rejection 4.3%
Focal Segmental Glomerulosclerosis 4.0%
Prophylaxis Of Nausea And Vomiting 3.0%
Prophylaxis Against Gastrointestinal Ulcer 2.5%
Multiple Sclerosis 2.0%
Relapsing-remitting Multiple Sclerosis 2.0%
Aplastic Anaemia 1.5%
White Blood Cell Count Increased 1.5%
Cytomegalovirus Infection 1.3%
Platelet Count Decreased 1.3%
Neurological Decompensation 15.7%
Pruritus 11.8%
Arthritis 9.8%
Hypertension 9.8%
Simplex Virus Test Positive 9.8%
Hepatic Function Abnormal 7.8%
Visual Impairment 7.8%
Rheumatoid Arthritis 3.9%
Sepsis 3.9%
Drug Exposure During Pregnancy 2.0%
Epstein-barr Virus Infection 2.0%
Febrile Neutropenia 2.0%
Hepatic Failure 2.0%
Pemphigoid 2.0%
Pleurisy 2.0%
Renal Impairment 2.0%
Small For Dates Baby 2.0%
Thrombotic Microangiopathy 2.0%
White Blood Cell Count Decreased 2.0%
Concomitant
Asthma 25.4%
Prophylaxis 14.4%
Drug Use For Unknown Indication 12.5%
Juvenile Idiopathic Arthritis 8.7%
Product Used For Unknown Indication 6.7%
Bronchitis 4.4%
Renal Transplant 3.8%
Pneumonia 2.4%
Acute Lymphocytic Leukaemia 2.3%
Gastritis 2.3%
Constipation 2.0%
Hypertension 2.0%
Rheumatoid Arthritis 1.9%
Interstitial Lung Disease 1.9%
Multiple Sclerosis 1.8%
Nutritional Support 1.7%
Cancer Pain 1.5%
Pneumonia Aspiration 1.5%
Immunosuppression 1.4%
Insomnia 1.3%
Liver Disorder 16.0%
Pyrexia 8.0%
White Blood Cell Count Decreased 8.0%
Upper Respiratory Tract Inflammation 6.7%
Arthritis 4.9%
Febrile Neutropenia 4.9%
Interstitial Lung Disease 4.9%
Loss Of Consciousness 4.9%
Platelet Count Decreased 4.9%
Spinal Fracture 4.9%
Cerebral Infarction 4.3%
Death 3.7%
Pancytopenia 3.7%
Pneumonia Bacterial 3.1%
Renal Failure 3.1%
Sepsis 3.1%
Thrombotic Microangiopathy 3.1%
Transplant Rejection 3.1%
Depressed Level Of Consciousness 2.5%
Pneumocystis Jirovecii Pneumonia 2.5%